These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14353049)

  • 21. Effects of conjugated linoleic acid on liver composition and fatty acid oxidation are isomer-dependent in hamster.
    Macarulla MT; Fernández-Quintela A; Zabala A; Navarro V; Echevarría E; Churruca I; Rodríguez VM; Portillo MP
    Nutrition; 2005 Apr; 21(4):512-9. PubMed ID: 15811773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
    Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assays of fatty acid beta-oxidation activity.
    Bennett MJ
    Methods Cell Biol; 2007; 80():179-97. PubMed ID: 17445695
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of three different conjugated linoleic acid preparations on insulin signalling, fat oxidation and mitochondrial function in rats fed a high-fat diet.
    Choi JS; Koh IU; Jung MH; Song J
    Br J Nutr; 2007 Aug; 98(2):264-75. PubMed ID: 17408517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism.
    Sharma V; Mustafa S; Patel N; Wambolt R; Allard MF; McNeill JH
    Eur J Pharmacol; 2009 Sep; 617(1-3):113-7. PubMed ID: 19573526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does increased fatty acid oxidation enhance development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III?
    Herrema H; Smit GP; Reijngoud DJ; Kuipers F
    J Hepatol; 2007 Aug; 47(2):298-300; author reply 300-1. PubMed ID: 17570555
    [No Abstract]   [Full Text] [Related]  

  • 27. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of fatty acid oxidation in chicken (Gallus gallus): interactions between genotype and diet composition.
    Collin A; Swennen Q; Skiba-Cassy S; Buyse J; Chartrin P; Le Bihan-Duval E; Crochet S; Duclos MJ; Joubert R; Decuypere E; Tesseraud S
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):171-7. PubMed ID: 19258045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel inhibitors of fatty acid oxidation as potential metabolic modulators.
    Elzein E; Shenk K; Ibrahim P; Marquart T; Kerwar S; Meyer S; Ahmed H; Zeng D; Chu N; Soohoo D; Wong S; Leung K; Zablocki J
    Bioorg Med Chem Lett; 2004 Feb; 14(4):973-7. PubMed ID: 15013004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluxing the mitochondria to insulin resistance.
    Watt MJ; Hevener AL
    Cell Metab; 2008 Jan; 7(1):5-6. PubMed ID: 18177719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The activation of fatty acid oxidation by kidney and liver mitochondria.
    JUDAH JD; REES KR
    Biochem J; 1953 Nov; 55(4):664-8. PubMed ID: 13115352
    [No Abstract]   [Full Text] [Related]  

  • 33. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview.
    Holloway GP; Luiken JJ; Glatz JF; Spriet LL; Bonen A
    Acta Physiol (Oxf); 2008 Dec; 194(4):293-309. PubMed ID: 18510711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
    Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.
    Reddy JK; Rao MS
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G852-8. PubMed ID: 16603729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired fatty acid oxidation as a cause of liver disease associated with hyperemesis gravidarum.
    Outlaw WM; Ibdah JA
    Med Hypotheses; 2005; 65(6):1150-3. PubMed ID: 16040200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects.
    Fuda F; Narayan SB; Squires RH; Bennett MJ
    Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer.
    Zha S; Ferdinandusse S; Hicks JL; Denis S; Dunn TA; Wanders RJ; Luo J; De Marzo AM; Isaacs WB
    Prostate; 2005 Jun; 63(4):316-23. PubMed ID: 15599942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.